While we had previously demonstrated that PRG4 enhances drug sensitivity in HCC cells through two-dimensional in vitro cell proliferation assays, this study provides more robust support for those findings through a reliable in vivo model [23]. The gene discussed is PRG4; the disease is hepatocellular carcinoma.